An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE).

Name: An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE).
Author: Clouthier, Derek L

An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE). — المؤلف: Clouthier, Derek L — Journal for immunotherapy of cancer 20200616

المؤلف: Clouthier, Derek L
النشر: Journal for immunotherapy of cancer 20200616
الوصف: 72 p.
الموضوعات: Administration, Intravenous؛ Antibodies, Monoclonal, Humanized؛ Antineoplastic Agents, Immunological؛ Biomarkers, Tumor؛ Biopsy, Needle؛ Feasibility Studies؛ Female؛ Gene Dosage